Sapphire Star Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$709K Sell
5,500
-400
-7% -$55.8K 0.95% 34
2018
Q3
$815K Sell
5,900
-400
-6% -$53.2K 0.82% 43
2018
Q2
$765K Hold
6,300
0.79% 50
2018
Q1
$807K Buy
6,300
+600
+11% +$81.1K 0.89% 35
2017
Q4
$796K Sell
5,700
-3,500
-38% -$488K 0.94% 35
2017
Q3
$1.2M Sell
9,200
-3,200
-26% -$424K 1.55% 18
2017
Q2
$1.64M Sell
12,400
-1,200
-9% -$153K 2.07% 14
2017
Q1
$1.69M Sell
13,600
-300
-2% -$35.8K 1.93% 14
2016
Q4
$1.6M Sell
13,900
-1,303
-9% -$151K 1.78% 15
2016
Q3
$1.8M Sell
15,203
-574
-4% -$69.6K 2.17% 12
2016
Q2
$1.91M Buy
+15,777
New +$1.79M 2.45% 13

Other funds holding JNJ

Sapphire Star Partners's JNJ Position: Q4 2018 in Review

Sapphire Star Partners reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q4 2018, selling an estimated $55.8K and leaving 5,500 shares worth $709K. The position accounts for 0.95% of the portfolio, ranked #34.

Sapphire Star Partners first reported a position in JNJ in Q2 2016 and has held it in 11 quarters since. The position peaked at $1.91M in Q2 2016. 2,765 funds tracked by Wall St. Rank hold JNJ as of Q4 2018.

  • Sapphire Star Partners held 5,500 shares of Johnson & Johnson worth $709K as of Q4 2018.
  • Sapphire Star Partners sold 400 Johnson & Johnson shares in Q4 2018, an estimated $55.8K.
  • Johnson & Johnson made up 0.95% of Sapphire Star Partners's portfolio in Q4 2018, its #34 holding.
  • Sapphire Star Partners first reported a position in Johnson & Johnson in Q2 2016 and has held it in 11 quarters since.
  • Sapphire Star Partners's Johnson & Johnson position peaked at $1.91M in Q2 2016.
  • 2,765 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.